May 22 |
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
|
May 1 |
InterCure reports FY results
|
May 1 |
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
|
Apr 22 |
InterCure: Bargain Israel Cannabis Play
|
Apr 1 |
InterCure sees annual revenue of NIS 351 million
|
Apr 1 |
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
|
Mar 22 |
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
|
Feb 13 |
InterCure provides update regarding its Nir Oz facility
|
Feb 13 |
InterCure Provides an Update Regarding Nir Oz Facility
|
Jan 31 |
InterCure to buy Isreal-based Leon cannabis pharmacy chain
|